Definitive Contract 75F40123C00183
- Not listed
- The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
- This is a $1,206,589.24 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is for research and development to quantify patient priorities for clinical evidence on the impact of osseointegrated limb prostheses. This award was made under the FDA's Broad Agency Announcement for regulatory science and innovation research, with no set-aside designation. Duke University has previously received...
- This federal contract award, valued at $400,734.35, was made by the Defense Health Agency to Duke University, a private non-profit university, for a new research contract. The award does not have a set-aside designation. The contract is a definitive contract of the cost-no-fee pricing type, with a performance period ending on December 29, 2018. Duke University's Office of Research Administration Division is the prime contractor. The award indicates that Duke University has been awarded...
- This is a $2,394,965.00 delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Duke University. The contract is part of the Best Pharmaceuticals for Children Act - Pediatric Trials Network (BPCA-PTN) major program and will support pharmacoepidemiology (real-world data) studies. The contract has no set-aside designation and has an ultimate completion date of May 31, 2026. As a prominent private research university, Duke...
- Duke University, a private non-profit educational institution, was awarded a $13,082,628.82 federal contract by an unspecified government agency to provide Biomedical (Applied/Exploratory) services. The contract, which does not have a set-aside designation, is a Definitive Contract with a Cost No Fee pricing type. The period of performance runs from the award date of September 15, 1996 through the completion date of February 28, 2005. The place of performance is Durham, North Carolina. Duke...
- This federal contract award was granted by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Duke University, a private university and non-profit organization. The $105,506.22 firm fixed-price purchase order is for a study or assessment, with a period of performance ending on May 1, 2017. The contract does not have a set-aside designation. Duke University has a robust track record of receiving federal contracts and grants from agencies such as the National...
- This contract award, valued at $5,759,708.00, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Duke University, a private university located in Durham, North Carolina. The purpose of this task order is to identify remaining gaps in off-label use of drugs in children and to design clinical research, including systematic literature reviews, epidemiology studies, population pharmacokinetic modeling studies, and research into innovative safety...
- This is a $740,997 firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Duke University for research and development related to digital health technologies for infectious disease monitoring. The contract is not set aside under any small business program. Duke University is a prominent private research university with extensive experience managing federal contracts and grants across scientific and...
- This federal contract award was made by the Naval Sea Systems Command (NAVSEA), a defense agency, to Duke University, a private research university. The contract, valued at $1,991,019.00, is for a research study with a final completion date of February 13, 2030. The contract type is a definitive contract with a cost-no-fee pricing structure. Duke University has also been awarded a significant single-award Indefinite Delivery Vehicle (IDV) with the National Institute of Allergy and Infectious...
- This federal contract award is for a research study valued at $327,939.00 and awarded to Duke University, a private research institution located in Durham, North Carolina. The contract was awarded by the Naval Sea Systems Command, a defense agency, and does not have a set-aside designation. The contract work involves a wide range of research activities for the government, including pediatric clinical trials, developing protocols for the Best Pharmaceuticals for Children Act Pediatric Trials...
This is a federal contract awarded by the Food and Drug Administration (FDA) to Duke University, a prestigious private research institution located in Durham, North Carolina. The $748,779.00 definitive contract is for Duke University to perform a targeted review of literature regarding quality of life of patients with overactive bladder (OAB) and the use of the LURN SI-10 measure, and to elicit the relative importance of LURN SI-10 items from the patients' perspective using a preference-elicitation instrument. The contract is not set aside and represents a competitive award based on Duke University's extensive research capabilities across multiple scientific disciplines. Duke University is a leading provider of advanced research, educational services, and scientific innovation to the federal government, and has a significant indefinite delivery contract with the National Institute of Child Health and Human Development for the Best Pharmaceuticals for Children Act Pediatric Trials Network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 8/22/25 | |
| Not listed | Not listed | $748.8k | 9/26/23 |